METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA
Clinical trials for METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New attack on tough breast cancer: radiation supercharges immune therapy
Disease control Not yet recruitingThis study is testing whether adding a short, high-dose course of radiation to standard immunotherapy and chemotherapy can better control an aggressive type of breast cancer that has spread. It will involve about 29 patients whose cancer has a specific marker (PD-L1 positive). Th…
Matched conditions: METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Blood pressure pill may reboot cancer treatment for Tough-to-Treat breast cancer
Disease control Not yet recruitingThis study is for people with advanced triple-negative breast cancer that has stopped responding to a standard immunotherapy drug (pembrolizumab). Researchers want to see if adding a common, low-cost blood pressure drug called propranolol can 're-sensitize' the cancer, making the…
Matched conditions: METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC